« Previous
Next »
European Journal of Radiology
Volume 73, Issue 2
, Pages 280-287
, February 2010
Imaging anti-angiogenic treatment response with DCE-VCT, DCE-MRI and DWI in an animal model of breast cancer bone metastasis
References
- . Skeletal complications of malignancy. Cancer. 1997;80:1588–1594
- Paclitaxel plus bevacizumab versus paclitaxel alone for metastatic breast cancer. N Engl J Med. 2007;357:2666–2676
- Bevacizumab inhibits breast cancer induced osteolysis, surrounding soft tissue metastasis, and angiogenesis in rats as visualized by VCT and MRI. Neoplasia. 2008;10:511–520
- . Assessment of response to therapy in advanced breast cancer. Br J Cancer. 1997;35:292–298
- . WHO handbook for reporting results of cancer treatment. Geneva: World Health Organization Offset Publication; 1979;
- New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada. J Natl Cancer Inst. 2000;92:205–216
- . Bone imaging in metastatic breast cancer. J Clin Oncol. 2004;22:2942–2953
- . Pharmacokinetic parameters in CNS Gd-DTPA enhanced MR imaging. J Comput Assist Tomogr. 1991;15:621–628
- Functional magnetic resonance tomography in the diagnosis and therapy monitoring in multiple myeloma. Radiologe. 2000;40:723–730
- Bone marrow microcirculation analysis in multiple myeloma by contrast-enhanced dynamic magnetic resonance imaging. Int J Cancer. 2001;93:862–868
- Lumbar bone marrow microcirculation measurements from dynamic contrast-enhanced magnetic resonance imaging is a predictor of event-free survival in progressive multiple myeloma. Clin Cancer Res. 2007;13:475–481
- . Characterization of a rat model with site-specific bone metastasis induced by MDA-MB-231 breast cancer cells and its application to the effects of an antibody against bone sialoprotein. Int J Cancer. 2005;115:177–186
- Dynamic T1-weighted monitoring of vascularization in human carcinoma heterotransplants by magnetic resonance imaging. Int J Cancer. 2003;104:113–120
- . Metastasis to bone: causes, consequences and therapeutic opportunities. Nat Rev Cancer. 2002;2:584–593
- . The skeleton as a unique environment for breast cancer cells. Clin Exp Metastasis. 2003;20:275–284
- . The radiological demonstration of osseous metastases. Experimental observations. Clin Radiol. 1967;18:159–162
- An imaging biomarker of early treatment response in prostate cancer that has metastasized to the bone. Cancer Res. 2007;67:3524–3528
- Dynamic contrast-enhanced magnetic resonance imaging rapidly indicates vessel regression in human squamous cell carcinomas grown in nude mice caused by VEGF receptor 2 blockade with DC101. Neoplasia. 2004;6:213–223
- Combined use of DCE-MRI and VSI to monitor an antiangiogenic therapy against VEGF in tumor xenografts. In: Abstract of the 16th Annual Scientific Meeting of the International Society for Magnetic Resonance in Medicine (ISMRM). 2008;
- A feasibility study evaluating the functional diffusion map as a predictive imaging biomarker for detection of treatment response in a patient with metastatic prostate cancer to the bone. Neoplasia. 2007;9:1003–1011
PII: S0720-048X(08)00578-0
doi: 10.1016/j.ejrad.2008.10.020
© 2008 Elsevier Ireland Ltd. All rights reserved.
« Previous
Next »
European Journal of Radiology
Volume 73, Issue 2
, Pages 280-287
, February 2010
